CatalystFDA/Bio

Pfizer-backed Priovant wins FDA approval for lead asset

FDA approval validates Priovant's lead asset, backed by Pfizer.

What changed

FDA approval validates Priovant's lead asset, backed by Pfizer.

Why it matters

FDA approval validates Priovant's lead asset, backed by Pfizer. — impact context not separately stored; see What changed.

Sources